Daily non-political popular news in brief.

Patients with soft tissue sarcomas should be treated at high volume centers

Soft tissue sarcomas -- rare tumors of the connective tissue -- should be treated at the few centers which see most cases, in order to give patients the best chance of good outcomes, concludes an analysis of sarcoma management in Florida, published in the Annals of Surgery last month.

Read more »

Keywords: patients, soft, tissue, sarcomas, treated, volume, centers, patient, sarcoma, center

« Previous | Next »

Similar news on "Patients with soft tissue sarcomas should be treated at high volume centers":

1. Co-operation between GSF and clinic improves outlook for sarcoma patients
   07-13-2007 · EurekAlert!
   Hyperthermia, combined with chemotherapy, improves the chances of healing and survival of patients with low-lying, soft tissue sarcomas. At the Annual General Meeting of the American Society of Clinical Oncology in Chicago, the GSF scientist Professor Dr. Rolf D. Issels, presented the results of the first, randomized worldwide phase III study in which the effectiveness and superiority of the combined-therapy methods are proven, in comparison with results from chemotherapy alone.
   Similar news · Read more »
   
2. Pre-treatment blood test could guide lung cancer therapy
   06-05-2007 · EurekAlert!
   A multi-center team, led by Vanderbilt-Ingram Cancer Center investigators, has developed a new pre-treatment blood test that predicts which non-small-cell lung cancer patients will live longer when they are treated with certain targeted cancer therapies (Iressa, Tarceva). The mass spectrometry-based test, described in the June 6 Journal of the National Cancer Institute, may allow physicians to select the most beneficial therapy for each lung cancer patient, a step forward in the era of personalized medicine.
   Similar news · Read more »
   
3. Study profiles rural individuals most likely to have recurrent trauma center admissions
   01-15-2007 · EurekAlert!
   About 3.4 percent of patients treated in rural trauma centers appear to be recidivists, meaning that they have visited the facility more than once for separate injuries, according to a report in the January issue of Archives of Surgery, one of the JAMA/Archives journals. Substance abuse appears to be the common feature among urban and rural recurrent trauma patients.
   Similar news · Read more »
   
4. Research shows survival benefit for leukemia patients treated with arsenic trioxide
   06-04-2007 · EurekAlert!
   Through participation in a government-sponsored multi-year study, researchers at the Comprehensive Cancer Center at Wake Forest University have helped confirm that arsenic trioxide -- marketed as Trisenox -- significantly improves patient survival when coupled with standard chemotherapy treatment in newly diagnosed patients with acute promyelocytic leukemia, or APL.
   Similar news · Read more »
   
5. Government restrictions on weight loss surgeries limit access for poor, underinsured patients
   10-30-2007 · EurekAlert!
   Thresholds limiting bariatric surgeries to high-volume centers disproportionately restrict access for poor and underinsured patients, populations which are among the most in need of them, an analysis led by UT Southwestern Medical Center researchers shows.
   Similar news · Read more »
   
6. Patients treated for OSA at an AASM accredited sleep center more likely to adhere to CPAP
   06-12-2007 · EurekAlert!
   Access to specialized services with a structured management protocol for obstructive sleep apnea (OSA) and close follow-up in a sleep center accredited by the American Academy of Sleep Medicine improves CPAP compliance and is a model for development in sleep centers.
   Similar news · Read more »
   
7. Government restrictions on weight loss surgeries limit access for poor, underinsured patients, study shows
   10-30-2007 · UT Southwestern Medical Center
   Thresholds limiting bariatric surgeries to high-volume centers disproportionately restrict access for poor and underinsured patients, populations which are among the most in need of them, an analysis led by UT Southwestern Medical Center researchers shows.
   Similar news · Read more »
   
8. Study examines risk of soft tissue sarcomas in hereditary retinoblastoma survivors
   01-02-2007 · EurekAlert!
   A study in the Jan. 3 issue of the Journal of the National Cancer Institute quantifies the risk of hereditary retinoblastoma survivors developing specific subtypes of soft tissue sarcomas and finds that this risk persists for decades after the original retinoblastoma diagnosis. The findings emphasize the importance of regular medical surveillance for these patients, the authors say.
   Similar news · Read more »
   
9. CTRC enrolls first patients in Novel Phase II study for sarcoma -- Living virus destroys cancer cell
   07-24-2007 · EurekAlert!
   The Cancer Therapy & Research Center Institute for Drug Development, in collaboration with Oncolytics Biotech Inc., a biotechnology company, has enrolled the first two patients in a new Phase II clinical study for patients with various types of sarcomas that have metastasized to the lung. The novel anti-cancer therapy, REOLYSIN, is a living virus, not a chemotherapy drug, that is toxic to cancer cells but not harmful to normal cells.
   Similar news · Read more »
   
10. Disparities among patients with extremity soft-tissue sarcomas
    01-22-2008 · EurekAlert!
    A new study reveals significant racial and ethnic differences in the treatment and survival of patients with soft-tissue sarcomas, a rare but dangerous cancer that begins in muscle, fat, blood vessels or other supporting tissue of the body.
    Similar news · Read more »